Published in Apoptosis on January 01, 1997
Short-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation. Blood (2001) 1.19
Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats. Gut (2001) 1.07
Cure of colon cancer metastasis in rats with the new lipid A OM 174. Apoptosis of tumor cells and immunization of rats. Clin Exp Metastasis (1999) 0.84
Opposite role of Bax and BCL-2 in the anti-tumoral responses of the immune system. BMC Cancer (2004) 0.80
Enhanced killing of SCC17B human head and neck squamous cell carcinoma cells after photodynamic therapy plus fenretinide via the de novo sphingolipid biosynthesis pathway and apoptosis. Int J Oncol (2015) 0.75
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol (2012) 5.32
Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie. N Engl J Med (1998) 4.93
Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst (1991) 4.24
Molecular and cellular biology of cholinesterases. Prog Neurobiol (1993) 3.01
Impairing the bioenergetic status and the biogenesis of mitochondria triggers mitophagy in yeast. Cell Death Differ (2005) 2.73
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol (1994) 2.66
Analysis of calf-thymus satellite DNA: evidence for specific methylation of cytosine in C-G sequences. Eur J Biochem (1977) 2.47
Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. J Clin Oncol (2002) 2.15
Interactions of heteroaromatic compounds with nucleic acids. A - T-specific non-intercalating DNA ligands. Eur J Biochem (1975) 1.93
ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists. Int J Radiat Oncol Biol Phys (1991) 1.91
Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid. Clin Infect Dis (1992) 1.89
The expression of tetracycline resistance after insertion of foreign DNA fragments between the EcoRI and HindIII sites of the plasmid cloning vector pBR 322. Mol Gen Genet (1978) 1.77
Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy. J Clin Oncol (1997) 1.67
An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis. Gastroenterology (1994) 1.49
Liver ischemia for hepatic resection: where is the limit? Surgery (1992) 1.48
TOM22, a core component of the mitochondria outer membrane protein translocation pore, is a mitochondrial receptor for the proapoptotic protein Bax. Cell Death Differ (2006) 1.47
Lectin binding to serum 5'-nucleotidase and alkaline phosphatase in liver disease. Clin Chim Acta (1990) 1.45
Enzyme-linked immunosorbent assay for screening monoclonal antibody production using enzyme-labeled second antibody. Methods Enzymol (1983) 1.42
Immunoscintigraphy of colon carcinoma. J Nucl Med (1984) 1.31
Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard. Oncologist (2001) 1.29
Small cell carcinoma of the esophagus: analysis of 10 cases and review of the published data. Am J Clin Oncol (2000) 1.27
Technique of hepatic vascular exclusion for extensive liver resection. Am J Surg (1992) 1.27
Targeted therapy in metastatic colorectal cancer -- an example of personalised medicine in action. Cancer Treat Rev (2013) 1.24
Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma. J Natl Cancer Inst (1992) 1.22
On auxotrophy for pyrimidines of respiration-deficient chick embryo cells. Eur J Biochem (1984) 1.22
Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy. Curr Mol Pharmacol (2009) 1.21
Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis. Mol Cell (2001) 1.21
Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma. Lung Cancer (1994) 1.20
Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. Cancer Res (1983) 1.16
The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am J Transplant (2012) 1.15
The use of plasmid R1162 and derivatives for gene cloning in the methanol-utilizing Pseudomonas AM1. Mol Gen Genet (1980) 1.13
Repeat hepatic resection for primary and metastatic carcinoma of the liver. Surg Gynecol Obstet (1990) 1.09
Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats. Gut (2001) 1.07
Involvement of the N-terminus of Bax in its intracellular localization and function. FEBS Lett (2002) 1.06
Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development. Int J Cancer (1999) 1.03
Pharmacokinetics and pharmacodynamics of irinotecan during a phase II clinical trial in colorectal cancer. Pharmacology and Molecular Mechanisms Group of the European Organization for Research and Treatment of Cancer. J Clin Oncol (1996) 1.02
Spontaneous, persistent infection of a B-cell lymphoma with adenovirus. J Med Virol (1996) 1.01
Prostaglandins antagonistically control Bax activation during apoptosis. Cell Death Differ (2010) 1.01
Induction of a caspase-3-like activity by calcium in normal cytosolic extracts triggers nuclear apoptosis in a cell-free system. J Biol Chem (1998) 1.00
Increase in PGE2 biosynthesis induces a Bax dependent apoptosis correlated to patients' survival in glioblastoma multiforme. Oncogene (2007) 1.00
Impact of the DNA methyltransferases expression on the methylation status of apoptosis-associated genes in glioblastoma multiforme. Cell Death Dis (2010) 1.00
Collision of primary malignant neoplasms on the skin: the connection between malignant melanoma and basal cell carcinoma. Dermatology (1997) 1.00
'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'. Br J Cancer (2006) 0.99
H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells. Cancer Res (1994) 0.99
Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines. Cancer Res (1999) 0.98
Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesothelioma. Cancer (1994) 0.97
Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study. J Clin Oncol (1996) 0.97
Over-expression of the S13 ribosomal protein in actively growing cells. Int J Cancer (1993) 0.97
Prognostic impact of the expression/phosphorylation of the BH3-only proteins of the BCL-2 family in glioblastoma multiforme. Cell Death Dis (2012) 0.95
Short-chain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice. Cancer Res (1997) 0.95
The role of transforming growth factor beta 1 in the fibroblastic reaction associated with rat colorectal tumor development. Cancer Res (1994) 0.95
Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use. Cancer Immunol Immunother (2001) 0.95
Cytokines in metastatic renal cell carcinoma: is it useful to switch to interleukin-2 or interferon after failure of a first treatment? Groupe Français d'Immunothérape. J Clin Oncol (1999) 0.94
The C-terminus of bax is not a membrane addressing/anchoring signal. Biochem Biophys Res Commun (1999) 0.94
Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000). Br J Cancer (2003) 0.94
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer. Br J Cancer (2009) 0.94
Existence of an inactive pool of acetylcholinesterase in chicken brain. Proc Natl Acad Sci U S A (1993) 0.93
Coloanal anastomosis after resection of low rectal cancer in the elderly. World J Surg (1990) 0.93
Expression of bcl-2, bax and bcl-xl in human gliomas: a re-appraisal. J Neurooncol (2001) 0.92
Anti-idiotypic antibodies to monoclonal antibody CO17-1A. Hybridoma (1986) 0.92
Bax activation by engagement with, then release from, the BH3 binding site of Bcl-xL. Mol Cell Biol (2010) 0.92
Over-expression of a novel member of the immunoglobulin superfamily in Min mouse intestinal adenomas. Int J Cancer (1996) 0.92
Docetaxel (Taxotere) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer. Eur J Cancer (1998) 0.91
Relationship between the peptide-sensitive channel and the mitochondrial outer membrane protein translocation machinery. J Biol Chem (1997) 0.90
High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy. J Immunother (1991) (1991) 0.90
Electron microscopy study of intrahepatic ultrasmall superparamagnetic iron oxide kinetics in the rat. Relation with magnetic resonance imaging. Biol Cell (1999) 0.89
Cloning of calf thymus satellite I DNA in Escherichia coli. Mol Gen Genet (1976) 0.89
Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France: XELOX versus FOLFOX-6. Oncology (2011) 0.89
Repair of large chest wall defects: experience with 23 patients. Ann Thorac Surg (1981) 0.89
Increase of rat colon carcinoma cells tumorigenicity by alpha(1-2) fucosyltransferase gene transfection. Glycobiology (1997) 0.89
Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'Immunothérapie. J Clin Oncol (1998) 0.88
Rats injected with syngenic rat apoptotic neutrophils develop antineutrophil cytoplasmic antibodies. J Am Soc Nephrol (2001) 0.87
Responses of juvenile sea bass, Dicentrarchus labrax, exposed to acute concentrations of crude oil, as assessed by molecular and physiological biomarkers. Chemosphere (2012) 0.87
Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer. Oncologist (2001) 0.86
[Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer]. Bull Cancer (1996) 0.86
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer. Br J Cancer (2007) 0.86
Expression of the 100-kda glucose-regulated protein (GRP100/endoplasmin) is associated with tumorigenicity in a model of rat colon adenocarcinoma. Int J Cancer (1994) 0.86
Distinguishing characteristics of a new neuroblastoma cell line. Cancer Genet Cytogenet (1983) 0.86
Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer. J Nucl Med (1996) 0.86
Purification and properties of bovine liver plasma membrane 5' nucleotidase. Eur J Biochem (1983) 0.85
Difference in antigenic determinant profiles between human and rat myeloperoxidase. Clin Exp Immunol (2003) 0.85
Coxsackie B4 viral infection of the human kidney. J Urol (1974) 0.85
Expression of collagens type I and IV, osteonectin and transforming growth factor beta-1 (TGFbeta1) in biliary atresia and paucity of intrahepatic bile ducts during infancy. J Hepatol (1999) 0.85
Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's disease. Eur J Cancer Clin Oncol (1985) 0.85
Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: results of a phase I/II trial. Clin Cancer Res (1999) 0.85
Molecular forms of acetylcholinesterase in dystrophic (mdx) mouse tissues. Neuromuscul Disord (1992) 0.84